What are the current guidelines for the use of anticoagulation in patients with atrial flutter?
Abstract
The evidence suggests that anticoagulation management in atrial flutter mirrors that for atrial fibrillation, focusing on patients with elevated CHA2DS2-VASc scores and utilizing NOACs as the preferred therapy option.
Fields of Study & Subjects
Atrial Fibrillation Management and Outcomes
Cardiac Arrhythmias and Treatments
Venous Thromboembolism Diagnosis and Management
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 20 January 2026